These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20167050)

  • 21. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
    Greer AL
    BMC Public Health; 2013 Jul; 13():669. PubMed ID: 23866760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):82-86. PubMed ID: 24034490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIP 3: Epidemic and pandemic use of antivirals. Antivirals: "You're still the one...".
    Vaccine; 2009 Oct; 27(45):6377-9. PubMed ID: 19856486
    [No Abstract]   [Full Text] [Related]  

  • 25. Feds to stockpile antivirals as pandemic "speed bump".
    Lett D
    CMAJ; 2005 Apr; 172(9):1167. PubMed ID: 15788559
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiviral resistance and the control of pandemic influenza.
    Lipsitch M; Cohen T; Murray M; Levin BR
    PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are we prepared to help low-resource communities cope with a severe influenza pandemic?
    Starbuck ES; von Bernuth R; Bolles K; Koepsell J
    Influenza Other Respir Viruses; 2013 Nov; 7(6):909-13. PubMed ID: 23145978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.
    Moss RB; Davey RT; Steigbigel RT; Fang F
    J Antimicrob Chemother; 2010 Jun; 65(6):1086-93. PubMed ID: 20375034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of factors affecting intended and actual adherence with antiviral medication as treatment or prophylaxis in seasonal and pandemic flu.
    Smith LE; D'Antoni D; Jain V; Pearce JM; Weinman J; Rubin GJ
    Influenza Other Respir Viruses; 2016 Nov; 10(6):462-478. PubMed ID: 27397480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility.
    Balcan D; Hu H; Goncalves B; Bajardi P; Poletto C; Ramasco JJ; Paolotti D; Perra N; Tizzoni M; Van den Broeck W; Colizza V; Vespignani A
    BMC Med; 2009 Sep; 7():45. PubMed ID: 19744314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Outpatient Influenza Antiviral Use Among Children and Adolescents in the United States.
    Antoon JW; Sarker J; Abdelaziz A; Lien PW; Williams DJ; Lee TA; Grijalva CG
    Pediatrics; 2023 Dec; 152(6):. PubMed ID: 37953658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
    Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
    J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral treatment of influenza in children.
    Garg S; Fry AM; Patton M; Fiore AE; Finelli L
    Pediatr Infect Dis J; 2012 Feb; 31(2):e43-51. PubMed ID: 22252215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany.
    Reuss A; Dehnert M; Buda S; Haas W
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1427-32. PubMed ID: 23957666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of influenza antivirals on individual and population immunity over many epidemic waves.
    Pepin KM; Riley S; Grenfell BT
    Epidemiol Infect; 2013 Feb; 141(2):366-76. PubMed ID: 22459665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community.
    Xiao Y; Patel Z; Fiddler A; Yuan L; Delvin ME; Fisman DN
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1409-15. PubMed ID: 23879801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemic influenza in Mexico: the broken dogma and its lessons].
    Macías AE; De la Torre A; Bourlon MT; Leal PE; Moreno-Espinosa S; Huertas M; Domínguez-Cherit G; Galindo-Fraga A; Ruiz-Palacios GM
    Rev Invest Clin; 2009; 61(2):94-7. PubMed ID: 19637722
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacological management of severe influenza infection - 'existing and emerging therapies'.
    Mc Mahon A; Martin-Loeches I
    Expert Rev Clin Pharmacol; 2017 Jan; 10(1):81-95. PubMed ID: 27797595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
    Stilianakis NI; Perelson AS; Hayden FG
    J Infect Dis; 1998 Apr; 177(4):863-73. PubMed ID: 9534957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antivirals in the management of an influenza pandemic.
    Harrod ME; Emery S; Dwyer DE
    Med J Aust; 2006 Nov; 185(S10):S58-61. PubMed ID: 17115954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.